FRANCESCO DE RUBERTIS

Profile

First Name

: FRANCESCO

Middle Name

:

Last Name

: DE RUBERTIS

Related Companies
Titles
Company Name
Related People
DIRECTOR
NORMOXYS INC
CONRAD BLETZER, JR., CONRAD J. BLETZER, JR., DAVID CLARK, DR. JEAN-PIERRE GARNIER, JEAN-PIERRE GARNIER, ARGERIS KARABELAS, JEAN-MARIE LEHN, SARA MCKENZIE, CLAUDE NICOLAU, MICHELE OLLIER, MARTIN TOLAR
DIRECTOR
NORMOXYS, INC.
CONRAD BLETZER, JR., CONRAD J. BLETZER, JR., DAVID CLARK, DR. JEAN-PIERRE GARNIER, JEAN-PIERRE GARNIER, ARGERIS KARABELAS, JEAN-MARIE LEHN, SARA MCKENZIE, CLAUDE NICOLAU, MICHELE OLLIER, MARTIN TOLAR
DIRECTOR
VERSARTIS, INC.
SRINIVAS AKKARAJU, JOSHUA BRUMM, JEFFREY CLELAND, LEONARD SCOTT DOVE, MICHAEL DYBBS, FREDRIC N. ESHELMAN, ROBERT B. GELLER, AMATO GIACCIA, PETER T.C. HO, JOHN A. HOHNECKER, RUDY HOWARD, EDMON JENNINGS, KEVIN JOHNSON, SIGURD C. KIRK, SHAHZAD MALIK, GAIL MCINTYRE, MICHAEL W. ROGERS, VOLKER SCHELLENBERGER, JAY SHEPARD, WILLEM STEMMER, ANTHONY SUN, PAUL WESTBERG, ERIC ZHANG
DIRECTOR
MINERVA NEUROSCIENCES, INC.
FRED AHLHOLM, FREDERICK AHLHOLM, MARC BEER, HANS PETER HASLER, JERYL HILLEMAN, DAVID KUPFER, FOUZIA LAGHRISSI-THODE, MARK LEVINE, REMY LUTHRINGER, MICHELE OLLIER, GEOFF RACE, GEOFFREY RACE, JOSEPH REILLY, JAN VAN HEEK, NICO VANDERVELPEN
EXECUTIVE OFFICER
MEDICXI GROWTH I LP
DAVID GRAINGER, KEVIN JOHNSON, MICHELE OLLIER, GIUSEPPE ZOCCO
EXECUTIVE OFFICER
MEDICXI III LP
KEVIN JOHNSON, MICHELE OLLIER, GIUSEPPE ZOCCO
EXECUTIVE OFFICER
MEDICXI SECONDARY I LP
KEVIN JOHNSON, MICHELE OLLIER
DIRECTOR
RIVUS PHARMACEUTICALS, INC.
ALLEN CUNNINGHAM, JAYSON DALLAS, DEREK DIROCCO, PATRICK ENRIGHT, NANCY HARGREAVES, SHAHARYAR KHAN, ERIN LAVELLE, TOM O-NEIL, ROBERT SCHOTT, IAN SMITH, RICK WINNINGHAM
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-07 
2024-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-09 
2024-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-19 
2021-10-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-26 
2020-09-21
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-09-04 
2019-07-10
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-06-21 
2016-11-22
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-11-08 
2016-03-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-03-17 
2015-03-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-18 
2014-02-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-14 
2014-02-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-04 
2013-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-01 
2013-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-08 
2011-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-07 
2011-06-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-10 
2010-05-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-10 
2010-03-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-21 
2009-04-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-22